Authors: Thomsen, C Valsborg, JS Platou, J Martin, J Foged, C Johansen, NL Olsen, UB Madsen, K

Citation: C. Thomsen et al., [H-3]ac-RYYRWK-NH2, a novel specific radioligand for the nociceptin/orphanin FQ receptor, N-S ARCH PH, 362(6), 2000, pp. 538-545

Authors: Knudsen, LB Nielsen, PF Huusfeldt, PO Johansen, NL Madsen, K Pedersen, FZ Thogersen, H Wilken, M Agerso, H

Citation: Lb. Knudsen et al., Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration, J MED CHEM, 43(9), 2000, pp. 1664-1669

Authors: Peschke, B Ankersen, M Hansen, BS Hansen, TK Johansen, NL Lau, J Madsen, K Petersen, H Thogersen, H Watson, B

Citation: B. Peschke et al., Synthesis and in vitro characterization of new growth hormone secretagogues derived from ipamorelin with dipeptidomimetic N-terminals, EUR J MED C, 34(5), 1999, pp. 363-380

Authors: Ankersen, M Hansen, BS Hansen, TK Lau, J Peschke, B Madsen, K Johansen, NL

Citation: M. Ankersen et al., Demonstration of the strength of focused combinatorial libraries in SAR optimisation of growth hormone secretagogues, EUR J MED C, 34(10), 1999, pp. 783-790

Authors: Raun, K Hansen, BS Johansen, NL Thogersen, H Madsen, K Ankersen, M Andersen, PH

Citation: K. Raun et al., Ipamorelin, the first selective growth hormone secretagogue, EUR J ENDOC, 139(5), 1998, pp. 552-561

Authors: Johansen, PB Hansen, KT Andersen, JV Johansen, NL

Citation: Pb. Johansen et al., Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormonesecretagogues with emphasis on nasal absorption, XENOBIOTICA, 28(11), 1998, pp. 1083-1092